Literature DB >> 9400355

Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.

B C Tilley1, P D Lyden, T G Brott, M Lu, S R Levine, K M Welch.   

Abstract

OBJECTIVE: To develop an approach for reducing time between emergency department (ED) admission and treatment in patients with acute ischemic stroke to meet the challenge of providing tissue plasminogen activator treatment within 180 minutes.
DESIGN: An observational study.
SETTING: Forty trial-affiliated hospitals, including 30 community hospitals. PARTICIPANTS: A total of 17,324 consecutive patients admitted to trial-affiliated hospital EDs within 24 hours of possible stroke, from January 1991 through October 1994. INTERVENTION: Appraisal of the process of triage, evaluation, diagnosis, and treatment by means of total quality improvement techniques in each hospital. Staff participating in the process identified sources of variation and modifications by flow charting the process. MAIN OUTCOME MEASURE: Time between ED admission and treatment with study medication.
RESULTS: Total quality improvement methods identified hospital-specific process improvements. Many improvements were administrative, requiring no additional resources. More than 50% of screened patients arrived too late to be treated. Only 1268 patients were admitted between 0 and 125 minutes from stroke onset with no other trial exclusion criteria; 48% were treated. Of 243 patients admitted between 126 and 170 minutes from stroke onset with no exclusion criteria, 4% were treated. Mean time from ED admission to treatment was similar in teaching and community hospitals.
CONCLUSIONS: Total quality improvement methods identified ED-specific sources of process variability and reduced time between ED admission and treatment. Therefore, these methods should be considered in developing and monitoring emergent stroke treatment protocols.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9400355     DOI: 10.1001/archneur.1997.00550240020008

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  20 in total

Review 1.  Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers.

Authors:  Wei Wang; Mingchang Li; Qianxue Chen; Jian Wang
Journal:  Mol Neurobiol       Date:  2014-11-04       Impact factor: 5.590

Review 2.  Management of acute ischaemic stroke in the elderly: tolerability of thrombolytics.

Authors:  D Tanne; D Turgeman; Y Adler
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Strokes with minor symptoms: an exploratory analysis of the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator trials.

Authors:  Pooja Khatri; Dawn O Kleindorfer; Sharon D Yeatts; Jeffrey L Saver; Steven R Levine; Patrick D Lyden; Charles J Moomaw; Yuko Y Palesch; Edward C Jauch; Joseph P Broderick
Journal:  Stroke       Date:  2010-09-02       Impact factor: 7.914

Review 4.  The role of clinical pathways in reducing the economic burden of stroke.

Authors:  D J Lanska
Journal:  Pharmacoeconomics       Date:  1998-08       Impact factor: 4.981

5.  Mechanical Thrombectomy of Large Artery Occlusion Is Beneficial in Octogenarians.

Authors:  Simo Karhi; Ossi Nerg; Tuuli Miettinen; Emmi Mäkipaakkanen; Mikko Taina; Hannu Manninen; Ritva Vanninen; Pekka Jäkälä
Journal:  In Vivo       Date:  2018 Sep-Oct       Impact factor: 2.155

6.  Thrombolytic Therapy for Acute Ischemic Stroke.

Authors:  Patrick D Lyden
Journal:  Stroke       Date:  2019-07-22       Impact factor: 7.914

7.  Design of a cluster-randomized minority recruitment trial: RECRUIT.

Authors:  Barbara C Tilley; Arch G Mainous; Daniel W Smith; M Diane McKee; Rossybelle P Amorrortu; Jennifer Alvidrez; Vanessa Diaz; Marvella E Ford; Maria E Fernandez; Robert A Hauser; Carlos Singer; Veronica Landa; Aron Trevino; Stacia M DeSantis; Yefei Zhang; Elvan Daniels; Derrick Tabor; Sally W Vernon
Journal:  Clin Trials       Date:  2017-03-19       Impact factor: 2.486

Review 8.  Organization of regional and local stroke resources: methods to expedite acute management of stroke.

Authors:  James Kennedy; Christina Ma; Alastair M Buchan
Journal:  Curr Neurol Neurosci Rep       Date:  2004-01       Impact factor: 5.081

9.  Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial: design, rationale and implementation.

Authors:  Sarah Baraniuk; Barbara C Tilley; Deborah J del Junco; Erin E Fox; Gerald van Belle; Charles E Wade; Jeanette M Podbielski; Angela M Beeler; John R Hess; Eileen M Bulger; Martin A Schreiber; Kenji Inaba; Timothy C Fabian; Jeffrey D Kerby; Mitchell Jay Cohen; Christopher N Miller; Sandro Rizoli; Thomas M Scalea; Terence O'Keeffe; Karen J Brasel; Bryan A Cotton; Peter Muskat; John B Holcomb
Journal:  Injury       Date:  2014-06-10       Impact factor: 2.586

Review 10.  Intravenous rt-PA: a tenth anniversary reflection.

Authors:  James Grotta; John Marler
Journal:  Surg Neurol       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.